tazarotene has been researched along with clindamycin in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 3 (30.00) | 2.80 |
Authors | Studies |
---|---|
Draelos, ZD; Tanghetti, EA | 1 |
Shalita, A | 1 |
Abramovits, W; Loven, K; Shalita, A; Solomon, B; Tanghetti, E | 1 |
Bikowski, J; Callender, VD; Del Rosso, JQ; Draelos, ZD; Tanghetti, E | 1 |
Dhawan, S; Kircik, L; Tanghetti, E; Torok, H | 1 |
Dhawan, SS; Gwazdauskas, J | 1 |
Ashique Rahman, MA; Hota, D; Maiti, R; Parida, S; Sirka, CS; Srinivasan, A | 1 |
Guo, C; Huang, J; Li, L; Wang, XM; Yang, GP; Yang, S; Yang, XY; Ye, L; Zhang, XF | 1 |
Hang, TJ; Hu, ZL; Lu, YT; Shao, FX; Song, M | 1 |
Khattab, A; Nattouf, A | 1 |
7 trial(s) available for tazarotene and clindamycin
Article | Year |
---|---|
Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; California; Child; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Erythromycin; Facial Dermatoses; Female; Gels; Humans; Male; Nicotinic Acids; North Carolina; Severity of Illness Index; Treatment Outcome | 2002 |
Topical tazarotene: The BEST (balancing efficacy, speed, and tolerability) in acne trial.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Face; Female; Gels; Humans; Male; Nicotinic Acids; Retinoids; Risk Factors; Time Factors; Treatment Outcome; United States | 2004 |
Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Therapy, Combination; Emollients; Female; Humans; Male; Nicotinic Acids; Severity of Illness Index; Treatment Outcome; United States | 2006 |
Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Child; Clindamycin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gels; Humans; Keratolytic Agents; Male; Middle Aged; Nicotinic Acids; Ointments; Retinoids; Severity of Illness Index; Treatment Outcome; Tretinoin | 2007 |
Clindamycin phosphate 1.2%-benzoyl peroxide (5% or 2.5%) plus tazarotene cream 0.1% for the treatment of acne.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Chi-Square Distribution; Child; Clindamycin; Dermatologic Agents; Drug Combinations; Face; Female; Gels; Humans; Male; Nicotinic Acids; Ointments; Quality of Life; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome | 2013 |
Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Female; Gels; Humans; Male; Nicotinic Acids; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2017 |
Safety, Tolerability, and Pharmacokinetics of Tazarotene Clindamycin Cream: A Single-Dose, 3-Period Crossover Study.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Clindamycin; Cross-Over Studies; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Nicotinic Acids; Single-Blind Method; Young Adult | 2021 |
3 other study(ies) available for tazarotene and clindamycin
Article | Year |
---|---|
Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Keratolytic Agents; Male; Minocycline; Naphthalenes; Nicotinic Acids; Retinoids; Treatment Outcome; Tretinoin | 2006 |
Simultaneous determination of tazarotene, clindamycin phosphate and their active metabolites in Bama mini-pig skin by LC-MS/MS: Application to the development of a tazarotene/clindamycin phosphate cream.
Topics: Animals; Chromatography, Liquid; Clindamycin; Female; Linear Models; Male; Nicotinic Acids; Reproducibility of Results; Sensitivity and Specificity; Skin; Skin Cream; Swine; Swine, Miniature; Tandem Mass Spectrometry | 2021 |
Microsponge based gel as a simple and valuable strategy for formulating and releasing Tazarotene in a controlled manner.
Topics: Clindamycin; Drug Delivery Systems; Emulsifying Agents; Nicotinic Acids; Polymers | 2022 |